Rolando Gutierrez-Esteinou - Jun 17, 2021 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Chief Medical Officer
Signature
/s/ Ryan Barrett, Attorney-in-fact
Stock symbol
ATAI
Transactions as of
Jun 17, 2021
Transactions value $
$0
Form type
4
Date filed
6/22/2021, 04:15 PM
Next filing
Mar 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Stock Option Award $0 +752K $0.00 752K Jun 17, 2021 Common Shares 752K $15.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the underlying shares on June 17, 2022, and the remaining vests in 36 equal monthly installments thereafter.